Annual revenue:
$434.43M+$374.43M(+624.06%)Summary
- As of today (July 1, 2025), PTGX annual revenue is $434.43 million, with the most recent change of +$374.43 million (+624.06%) on December 31, 2024.
- During the last 3 years, PTGX annual revenue has risen by +$407.08 million (+1488.01%).
- PTGX annual revenue is now at all-time high.
Performance
PTGX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$28.32M-$142.32M(-83.40%)Summary
- As of today (July 1, 2025), PTGX quarterly revenue is $28.32 million, with the most recent change of -$142.32 million (-83.40%) on March 1, 2025.
- Over the past year, PTGX quarterly revenue has dropped by -$226.63 million (-88.89%).
- PTGX quarterly revenue is now -88.89% below its all-time high of $254.95 million, reached on March 31, 2024.
Performance
PTGX Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$207.80M-$226.63M(-52.17%)Summary
- As of today (July 1, 2025), PTGX TTM revenue is $207.80 million, with the most recent change of -$226.63 million (-52.17%) on March 1, 2025.
- Over the past year, PTGX TTM revenue has dropped by -$107.15 million (-34.02%).
- PTGX TTM revenue is now -52.17% below its all-time high of $434.43 million, reached on December 31, 2024.
Performance
PTGX TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
PTGX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +624.1% | -88.9% | -34.0% |
| 3 y3 years | +1488.0% | +10.1% | +343.2% |
| 5 y5 years | +10000.0% | +676.6% | +1142.5% |
PTGX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1534.4% | -88.9% | +3197.0% | -52.2% | +356.9% |
| 5 y | 5-year | at high | >+9999.0% | -88.9% | +3197.0% | -52.2% | +1142.5% |
| alltime | all time | at high | >+9999.0% | -88.9% | +445.8% | -52.2% | >+9999.0% |
PTGX Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $28.32M(-83.4%) | $207.80M(-52.2%) |
| Dec 2024 | $434.43M(+624.1%) | $170.64M(+3550.0%) | $434.43M(+34.2%) |
| Sep 2024 | - | $4.67M(+12.2%) | $323.80M(+1.5%) |
| Jun 2024 | - | $4.17M(-98.4%) | $319.12M(+1.3%) |
| Mar 2024 | - | $254.95M(+324.9%) | $314.95M(+424.9%) |
| Dec 2023 | $60.00M(+125.7%) | $60.00M(+6884.9%) | $60.00M(+31.9%) |
| Dec 2022 | $26.58M(-2.8%) | - | - |
| Jun 2022 | - | $859.00K(-96.7%) | $45.48M(-3.0%) |
| Mar 2022 | - | $25.72M(+198.5%) | $46.89M(+71.4%) |
| Dec 2021 | $27.36M(-4.4%) | $8.62M(-16.2%) | $27.36M(+12.2%) |
| Sep 2021 | - | $10.29M(+354.1%) | $24.39M(-10.4%) |
| Jun 2021 | - | $2.27M(-63.4%) | $27.22M(-12.7%) |
| Mar 2021 | - | $6.19M(+9.5%) | $31.17M(+8.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $28.63M(>+9900.0%) | $5.65M(-56.9%) | $28.63M(+11.4%) |
| Sep 2020 | - | $13.11M(+110.9%) | $25.70M(+53.7%) |
| Jun 2020 | - | $6.22M(+70.5%) | $16.72M(+621.5%) |
| Mar 2020 | - | $3.65M(+34.1%) | $2.32M(+903.5%) |
| Dec 2019 | $231.00K(-99.3%) | $2.72M(-34.3%) | $231.00K(-271.1%) |
| Sep 2019 | - | $4.14M(-150.6%) | -$135.00K(-107.3%) |
| Jun 2019 | - | -$8.19M(-624.9%) | $1.84M(-91.5%) |
| Mar 2019 | - | $1.56M(-33.7%) | $21.70M(-29.8%) |
| Dec 2018 | $30.93M(+54.1%) | $2.35M(-61.5%) | $30.93M(-22.4%) |
| Sep 2018 | - | $6.12M(-47.6%) | $39.85M(-6.3%) |
| Jun 2018 | - | $11.67M(+8.3%) | $42.52M(+37.8%) |
| Mar 2018 | - | $10.78M(-4.4%) | $30.84M(+53.7%) |
| Dec 2017 | $20.06M | $11.28M(+28.5%) | $20.06M(+128.5%) |
| Sep 2017 | - | $8.78M | $8.78M |
FAQ
- What is Protagonist Therapeutics annual revenue?
- What is the all time high annual revenue for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual revenue year-on-year change?
- What is Protagonist Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly revenue year-on-year change?
- What is Protagonist Therapeutics TTM revenue?
- What is the all time high TTM revenue for Protagonist Therapeutics?
- What is Protagonist Therapeutics TTM revenue year-on-year change?
What is Protagonist Therapeutics annual revenue?
The current annual revenue of PTGX is $434.43M
What is the all time high annual revenue for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual revenue is $434.43M
What is Protagonist Therapeutics annual revenue year-on-year change?
Over the past year, PTGX annual revenue has changed by +$374.43M (+624.06%)
What is Protagonist Therapeutics quarterly revenue?
The current quarterly revenue of PTGX is $28.32M
What is the all time high quarterly revenue for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly revenue is $254.95M
What is Protagonist Therapeutics quarterly revenue year-on-year change?
Over the past year, PTGX quarterly revenue has changed by -$226.63M (-88.89%)
What is Protagonist Therapeutics TTM revenue?
The current TTM revenue of PTGX is $207.80M
What is the all time high TTM revenue for Protagonist Therapeutics?
Protagonist Therapeutics all-time high TTM revenue is $434.43M
What is Protagonist Therapeutics TTM revenue year-on-year change?
Over the past year, PTGX TTM revenue has changed by -$107.15M (-34.02%)